How the Brain MRI Fits Into an Alzheimer’s Diagnostic Workup

Learn what a brain MRI shows, what it rules out, and why treatment plans often require one.

A brain MRI, a detailed structural brain scan, fits into an Alzheimer's workup as a routine early step that supports diagnosis and rules out other causes. It does not diagnose Alzheimer's alone but helps doctors interpret memory loss in context. Families often wonder why imaging comes before answers. The scan gives shape to the exam findings and guides what test or care step comes next.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Why is imaging part of the first evaluation?

The American Academy of Neurology recommends structural imaging with noncontrast CT or MRI for every patient with dementia. The goal is to find brain lesions that can cause cognitive impairment.

The National Institute on Aging says doctors combine history, cognitive and neurologic exams, labs, and CT, MRI or PET to support an Alzheimer's diagnosis or point to another cause. Imaging sits alongside the bedside exam, not after it. the NIA diagnosis guide.

What does the doctor look for on MRI?

American Academy of Neurology guidance notes MRI is preferred over CT for suspected Alzheimer's. The reason is accurate three-dimensional measurement of the hippocampus and related memory structures.

Mayo Clinic Press describes typical Alzheimer's MRI as medial temporal-lobe atrophy, especially hippocampal shrinkage. Prominent white-matter lesions or infarcts suggest vascular disease or mixed dementia instead.

What else can MRI rule out?

A Practical Neurology review describes the primary workup role of MRI as exclusion. It can detect other causes that explain thinking problems and change care.

the Practical Neurology imaging review The same review notes about 5% of these findings are unsuspected before imaging yet potentially treatable. That possibility makes the scan useful even when Alzheimer's seems likely.

  • tumor
  • subdural hematoma
  • hydrocephalus
  • stroke
  • small-vessel disease

Why can't MRI settle the diagnosis alone?

Under the 2018 NIA-Alzheimer's Association framework, quantitative MRI atrophy is a neurodegeneration biomarker. It sits alongside amyloid PET, tau PET, FDG-PET and spinal-fluid tau, not as a stand-alone test.

American College of Radiology criteria warn that structural findings are often nonspecific. They have limited power alone to separate Alzheimer's from other dementias, so amyloid or tau confirmation is needed.

Why might treatment require another MRI?

A recent baseline brain MRI is required before starting lecanemab. It checks safety and gives a comparison point for later scans.

The FDA prescribing information for Leqembi also requires surveillance MRIs before the 5th, 7th and 14th infusions to detect swelling or bleeding linked to amyloid treatment. the FDA Leqembi label mirror.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.